1. Home
  2. LRMR vs FLXS Comparison

LRMR vs FLXS Comparison

Compare LRMR & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • FLXS
  • Stock Information
  • Founded
  • LRMR N/A
  • FLXS 2001
  • Country
  • LRMR United States
  • FLXS United States
  • Employees
  • LRMR N/A
  • FLXS N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • FLXS Home Furnishings
  • Sector
  • LRMR Health Care
  • FLXS Consumer Discretionary
  • Exchange
  • LRMR Nasdaq
  • FLXS Nasdaq
  • Market Cap
  • LRMR 183.8M
  • FLXS 175.4M
  • IPO Year
  • LRMR N/A
  • FLXS N/A
  • Fundamental
  • Price
  • LRMR $2.14
  • FLXS $29.53
  • Analyst Decision
  • LRMR Strong Buy
  • FLXS
  • Analyst Count
  • LRMR 8
  • FLXS 0
  • Target Price
  • LRMR $19.63
  • FLXS N/A
  • AVG Volume (30 Days)
  • LRMR 1.3M
  • FLXS 14.3K
  • Earning Date
  • LRMR 04-30-2025
  • FLXS 04-21-2025
  • Dividend Yield
  • LRMR N/A
  • FLXS 2.27%
  • EPS Growth
  • LRMR N/A
  • FLXS N/A
  • EPS
  • LRMR N/A
  • FLXS 2.55
  • Revenue
  • LRMR N/A
  • FLXS $437,284,000.00
  • Revenue This Year
  • LRMR N/A
  • FLXS $8.34
  • Revenue Next Year
  • LRMR N/A
  • FLXS $4.01
  • P/E Ratio
  • LRMR N/A
  • FLXS $11.91
  • Revenue Growth
  • LRMR N/A
  • FLXS 7.24
  • 52 Week Low
  • LRMR $1.61
  • FLXS $28.81
  • 52 Week High
  • LRMR $11.20
  • FLXS $65.87
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 54.85
  • FLXS 40.52
  • Support Level
  • LRMR $1.80
  • FLXS $29.84
  • Resistance Level
  • LRMR $2.33
  • FLXS $32.60
  • Average True Range (ATR)
  • LRMR 0.18
  • FLXS 1.03
  • MACD
  • LRMR 0.04
  • FLXS -0.04
  • Stochastic Oscillator
  • LRMR 90.00
  • FLXS 12.56

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

Share on Social Networks: